Thioaceatamide-induced intestinal-type cholangiocarcinoma in rat: An animal model recapitulating the multi-stage progression of human cholangiocarcinoma

Carcinogenesis

Volumn 25, Issue 4, 2004, Pages 631-636

  Yeh, Chun Nan ^a   Maitra, Anirban ^b   Lee, Kam Fai ^a   Jan, Yi Yin ^a   Chen, Miin Fu ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; DRINKING WATER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; PARAFFIN; THIOACETAMIDE; TYROSINE KINASE RECEPTOR; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; BODY WEIGHT; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER PREVENTION; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DYSPLASIA; GENE OVEREXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; INTESTINE METAPLASIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; METASTASIS; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; STROMA; UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DISEASE MODEL; HUMAN; INTESTINE TUMOR; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; CARCINOGENS; CHOLANGIOCARCINOMA; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; INTESTINAL NEOPLASMS; MALE; RATS; RATS, SPRAGUE-DAWLEY; THIOACETAMIDE; TIME FACTORS;

EID: 3042818975     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh037     Document Type: Article

References (34)

1. Ahrendt,S.A., Nakeeb,A. and Pitt,H.A. (2001) Cholangiocarcinoma. Clin. Liver Dis., 5, 191-218.
2. de Groen,P.C., Gores,G.J., LaRusso,N.F., Gunderson,L.L. and Nagorney, D.M. (1999) Biliary tract cancers. N. Engl. J. Med., 341, 1368-1378.
3. Albores-Saavedra,J., Henson,D.E. and Sobin,L.H. (1992) The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition. Cancer, 70, 410-414.
4. Bergquist,A., Glaumann,H., Stal,P., Wang,G.S. and Broome,U. (2001) Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma. J. Intern. Med., 249, 69-75.
5. Fleming,K.A., Boberg,K.M., Glaumann,H., Berquist,A., Smith,D. and Clausen,O.P. (2001) Biliary dysplasia as a marker of cholangiocarcinoma. in primary sclerosing cholangitis. J. Hepatol., 34, 360-365.
6. Shimonishi,T., Sasaki,M. and Nakanuma,Y. (2000) Precancerous lesions of intrahepatic cholangiocarcinoma. J. Hepatobiliary Pancreat. Surg., 7, 542-550.
7. Terada,T., Nakanuma,Y. and Sirica,A.E. (1998) Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis. Hum. Pathol., 29, 175-180.
8. Endo,K., Yoon,B.I., Pairojkul,C., Demetris,A.J. and Sirica,A.E. (2002) ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology, 36, 439-450.
9. Hansel,D.E., Rahman,A., Hidalgo,M. et al. (2003) Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am. J. Pathol., 163, 217-229.
10. Dasgupta,A., Chatterjee,R. and Chowdhury,J.R. (1981) Thioacetamide-induced hepatocarcinoma in rat. Oncology, 38, 249-253.
11. Park,T.J., Kim,H.S., Byun,K.H., Jang,JJ., Lee,Y.S. and Lim,I.K. (2001) Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma. Mol. Carcinogen., 30, 138-150.
12. Tsujimoto,T., Kuriyama,S., Tominaga,K. et al. (2001) Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers. Int. J. Oncol., 18, 41-47.
13. Elmore,L.W. and Sirica,A.E. (1993) 'Intestinal-type' of adenocarcinoma preferentially induced in right/caudate liver lobes of rats treated with furan. Cancer Res., 53, 254-259.
14. Al-Bader,A., Mathew,T.C., Abul,H., Al-Sayer,H., Singal,P.K. and Dashti,H.M. (2000) Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide. Mol. Cell. Biochem., 208, 1-10.
15. Lee,J.H., Rim,H.J. and Sell,S. (1997) Heterogeneity of the 'oval-cell' response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment. J. Hepatol., 26, 1313-1323.
16. Thamavit,W., Bhamarapravati,N., Sahaphong,S., Vajrasthira,S. and Angsubhakorn,S. (1978) Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res., 38, 4634-4639.
17. Flavell,D.J. and Lucas,S.B. (1983) Promotion of N-nitrosodimethylamine-initiated bile duct carcinogenesis in the hamster by the human liver fluke, Opisthorchis viverrini. Carcinogenesis, 4, 927-930.
18. Cheifetz,R.E., Davis,N.L. and Owen,D.A. (1996) An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma. and the role of epidermal growth factor receptor in ductal proliferation. Can. J. Surg., 39, 193-197.
19. Sirica,A.E. (1996) Biliary proliferation and adaptation in furan-induced rat liver injury and carcinogenesis. Toxicol. Pathol., 24, 90-99.
20. Fitzhugh,O.G. and Nielson,A.A. (1948) Liver tumors in rats fed thiourea or thioacetamide. Science, 108, 626-628.
21. Gupta,D.N. (1956) Acute changes in the liver after administration of thioacetamide. J. Pathol. Bacteriol., 72, 183-192.
22. Dashti,H., Jeppsson,B., Hagerstrand,I., Hultberg,B., Srinivas,U., Abdulla,M., Joelsson,B. and Bengrmark,S. (1987) Early biochemical and histological changes in rats exposed to a single injection of thioacetamide. Pharmacol. Toxicol., 60, 171-174.
23. Kuriyama,S., Tsujimoto,T., Nakatani,Y. et al. (1999) Sonographic estimation of liver tumor development induced by oral administration of thioacetamide in rat. In Vivo, 13, 129-134.
24. Al-Bader,A.A., Mathew,T.C., Al-Mosawi,M., Dashti,H.M., Kumar,D. and Singal,P.K. (2003) Thioacetamide induced changes in trace elements and kidney damage. J. Trace Elements Exp. Med., in press.
25. Gallagher,C.H., Gupta,D.N., Judah,J.D. and Rees,K.K. (1956) Biochemical changes in acute thioacetamide intoxication. J. Path. Bact., 72, 193-201.
26. Muller,D., Zimmerman,S.I. and Schiller,F. (1982) Drug metabolism in rat liver injured by thioacetamide. Arch. Toxicol., 5, 368-371.
27. Dashti,H.M., Mathew,T.C., Jadaon,M.M. and Ashkanani,E. (1997) Zinc and liver cirrhosis: biochemical and histopathologic assessment. Nutrition, 13, 206-212.
28. Lee,J.W., Shin,K.D., Lee.,M., Kim,E.J., Han,S.S., Han,M.Y., Ha,H., Jeong,T.C. and Koh,W.S, (2003) Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immumosuppression. Toxicol. Lett., 136, 163-172.
29. Barker,E.A. and Smuckler,E.A. (1972) Altered microsome function during acute thioacetamide poisoning. Mol. Pharmacol., 8, 318-326.
30. Morley,C.G. and Boyer,J.L. (1977) Stimulation of hepatocellular proliferation by a serum factor from thioacetamide-treated rats. Biochim. Biophys. Acta, 477, 165-176.
31. Praet,M.M. and Roels,H.J. (1984) Histogenesis of cholangiomas and cholangiocarcinomas in thioacetamide fed rats. Exp. Pathol., 26, 3-14.
32. Radaeva,S., Ferreira-Gonzalez,A. and Sirica,A.E. (1999) Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: a link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma. Hepatology, 29, 1453-1462.
33. Maulik,G., Shrikhande,A., Kijima,T., Ma,P.C., Monison,P.T. and Salgia,R. (2002) Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev., 13, 41-59.
34. Sirica,A.E., Lai,G.H. and Zhang,Z. (2001) Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies. J. Gastroenterol. Hepatol., 16, 363-372.